Skip to main content

The Role of Vitamin D in the Development, Exacerbation, and Severity of Asthma and Allergic Diseases

  • Chapter
  • First Online:

Part of the book series: Respiratory Medicine ((RM,volume 3))

Abstract

The prevalence of asthma and allergic disease continues to increase throughout the world, but particularly in westernized countries and countries that are rapidly transitioning to a westernized way of living. Since vitamin D deficiency has become prevalent, vitamin D likely has a role to play in the rise in prevalence of these disorders. However, there are two countervailing hypotheses regarding this role. The first hypothesis is that introduction of fortification of foods with vitamin D contributed to the allergy epidemic, due to the timing of this widespread fortification relative to the recognition of the asthma and allergy epidemic. However, given the documented deficiency in circulating vitamin D in various populations despite the fortification of foods, and the development of technologies that have made it more attractive for humans to spend more time indoors, the other hypothesis takes the opposite view that it is vitamin D deficiency that has made populations susceptible to the development of these disorders. This chapter will review the epidemiology of asthma and allergies, the epidemiology of vitamin D deficiency, the potential mechanisms by which vitamin D affects asthma and allergy risk, and the studies that have been performed to investigate the role of vitamin D. Finally, the chapter concludes with some recommendations for future studies.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Seaton A, Godden DJ, Brown K. Increase in asthma: a more toxic environment or a more susceptible population? Thorax. 1994;49(2):171–4.

    PubMed  CAS  Google Scholar 

  2. Devereux G, Seaton A. Diet as a risk factor for atopy and asthma. J Allergy Clin Immunol. 2005;115(6):1109–17.

    PubMed  Google Scholar 

  3. Masoli M, Fabian D, Holt S, Beasley R. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy. 2004;59(5):469–78.

    PubMed  Google Scholar 

  4. Mannino DM, Homa DM, Akinbami LJ, Moorman JE, Gwynn C, Redd SC. Surveillance for asthma—United States, 1980–1999. MMWR Surveill Summ. 2002;51(1):1–13.

    Google Scholar 

  5. Devereux G. The increase in allergic disease: environment and susceptibility. Proceedings of a symposium held at the Royal Society of Edinburgh, 4th June 2002. Clin Exp Allergy. 2003;33(3):394–406.

    PubMed  Google Scholar 

  6. (CDC) CfDCaP. Vital signs: asthma prevalence, disease characteristics, and self-management education: United States, 2001–2009. MMWR Morb Mortal Wkly Rep. 2011;60(17):547–52.

    Google Scholar 

  7. Moorman JE, Zahran H, Truman BI, Molla MT. Current asthma prevalence—United States, 2006–2008. MMWR Surveill Summ. 2011;60 Suppl 17:84–6.

    PubMed  Google Scholar 

  8. Barnett SB, Nurmagambetov TA. Costs of asthma in the United States: 2002–2007. J Allergy Clin Immunol. 2011;127(1):145–52.

    PubMed  Google Scholar 

  9. Sullivan PW, Ghushchyan VH, Slejko JF, Belozeroff V, Globe DR, Lin SL. The burden of adult asthma in the United States: evidence from the Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2011;127(2):363–9. e1-3.

    PubMed  Google Scholar 

  10. Flohr C. Recent perspectives on the global epidemiology of childhood eczema. Allergol Immunopathol (Madr). 2011;39(3):174–82.

    CAS  Google Scholar 

  11. Williams H, Stewart A, von Mutius E, Cookson W, Anderson HR. Is eczema really on the increase worldwide? J Allergy Clin Immunol. 2008;121(4):947–54. e15.

    PubMed  Google Scholar 

  12. Bjorksten B, Clayton T, Ellwood P, Stewart A, Strachan D. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol. 2008;19(2):110–24.

    PubMed  Google Scholar 

  13. Gergen PJ, Arbes Jr SJ, Calatroni A, Mitchell HE, Zeldin DC. Total IgE levels and asthma prevalence in the US population: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol. 2009;124(3):447–53.

    PubMed  Google Scholar 

  14. Ellis CN, Drake LA, Prendergast MM, et al. Cost of atopic dermatitis and eczema in the United States. J Am Acad Dermatol. 2002;46(3):361–70.

    PubMed  Google Scholar 

  15. Malone DC, Lawson KA, Smith DH, Arrighi HM, Battista C. A cost of illness study of allergic rhinitis in the United States. J Allergy Clin Immunol. 1997;99(1 Pt 1):22–7.

    PubMed  CAS  Google Scholar 

  16. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–81.

    PubMed  CAS  Google Scholar 

  17. Allgrove J. Is nutritional rickets returning? Arch Dis Child. 2004;89(8):699–701.

    PubMed  CAS  Google Scholar 

  18. Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142–52.

    PubMed  Google Scholar 

  19. Lamberg-Allardt C. Vitamin D in foods and as supplements. Prog Biophys Mol Biol. 2006;92(1):33–8.

    PubMed  CAS  Google Scholar 

  20. Lu Z, Chen TC, Zhang A, et al. An evaluation of the vitamin D3 content in fish: is the vitamin D content adequate to satisfy the dietary requirement for vitamin D? J Steroid Biochem Mol Biol. 2007;103(3–5):642–4.

    PubMed  CAS  Google Scholar 

  21. Sahota H, Barnett H, Lesosky M, Raboud JM, Vieth R, Knight JA. Association of vitamin D related information from a telephone interview with 25-hydroxyvitamin D. Cancer Epidemiol Biomarkers Prev. 2008;17(1):232–8.

    PubMed  CAS  Google Scholar 

  22. van der Mei IA, Blizzard L, Ponsonby AL, Dwyer T. Validity and reliability of adult recall of past sun exposure in a case-control study of multiple sclerosis. Cancer Epidemiol Biomarkers Prev. 2006;15(8):1538–44.

    PubMed  Google Scholar 

  23. Webb AR. Who, what, where and when—influences on cutaneous vitamin D synthesis. Prog Biophys Mol Biol. 2006;92(1):17–25.

    PubMed  CAS  Google Scholar 

  24. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet. 2010;376(9736):180–8.

    PubMed  CAS  Google Scholar 

  25. Vieth R, Bischoff-Ferrari H, Boucher BJ, et al. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007;85(3):649–50.

    PubMed  CAS  Google Scholar 

  26. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006;84(1):18–28.

    PubMed  CAS  Google Scholar 

  27. Hollis BW, Wagner CL, Drezner MK, Binkley NC. Circulating vitamin D(3) and 25-hydroxyvitamin D in humans: an important tool to define adequate nutritional vitamin D status. J Steroid Biochem Mol Biol. 2007;103:631–4.

    PubMed  CAS  Google Scholar 

  28. Ross AC, Taylor CL, Yaktine AL, Del Valle HB, editors. Dietary reference intakes for calcium and vitamin D. Washington: National Academies Press; 2010.

    Google Scholar 

  29. Heaney RP, Holick MF. Why the IOM recommendations for vitamin D are deficient. J Bone Miner Res. 2011;26(3):455–7.

    PubMed  CAS  Google Scholar 

  30. Vieth R. Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml). Best Pract Res Clin Endocrinol Metab. 2011;25(4):681–91.

    PubMed  CAS  Google Scholar 

  31. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc. 2006;81(3):353–73.

    PubMed  CAS  Google Scholar 

  32. Nesby-O’Dell S, Scanlon KS, Cogswell ME, et al. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third National Health and Nutrition Examination Survey, 1988–1994. Am J Clin Nutr. 2002;76(1):187–92.

    PubMed  Google Scholar 

  33. Kimlin M, Harrison S, Nowak M, Moore M, Brodie A, Lang C. Does a high UV environment ensure adequate vitamin D status? J Photochem Photobiol B. 2007;89(2–3):139–47.

    PubMed  CAS  Google Scholar 

  34. Binkley N, Novotny R, Krueger D, et al. Low vitamin D status despite abundant sun exposure. J Clin Endocrinol Metab. 2007;92(6):2130–5.

    PubMed  CAS  Google Scholar 

  35. US Environmental Protection Agency. Report to congress on indoor air quality, vol. II: Assessment and control of indoor air pollution. Report No. EPA 400-1-89-001C. Washington, DC: EPA; 1989.

    Google Scholar 

  36. Ginde AA, Liu MC, Camargo Jr CA. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Intern Med. 2009;169(6):626–32.

    PubMed  CAS  Google Scholar 

  37. Rappaport BZ, Reed CE. Viosterol of high potency in seasonal hay fever and related conditions. JAMA. 1933;101(2):105–9.

    CAS  Google Scholar 

  38. Rappaport BZ, Reed CI, Hathaway ML, Struck HC. The treatment of hay fever and asthma with viosterol of high potency. J Allergy. 1934;5(6):541–53.

    CAS  Google Scholar 

  39. Canon P. The therapy of nasal allergy; results obtained by high dose vitamin D therapy and calcium. Acta Otorhinolaryngol Belg. 1951;5(6):495–508.

    PubMed  CAS  Google Scholar 

  40. Jakso G. Studies on the anti-allergic effects of vitamin D2. Borgyogy Venerol Sz. 1950;4(7):223–5.

    PubMed  CAS  Google Scholar 

  41. Slovik DM, Neer RM, Ohman JL, et al. Parathyroid hormone and 25-hydroxyvitamin D levels in glucocorticoid-treated patients. Clin Endocrinol (Oxf). 1980;12(3):243–8.

    CAS  Google Scholar 

  42. Utz G, Hauck AM. Oral application of calcium and vitamin D2 in allergic bronchial asthma (author’s transl). MMW Munch Med Wochenschr. 1976;118(43):1395–8.

    PubMed  CAS  Google Scholar 

  43. Weicksel. Antiallergic action of vigantol. Z Tuberk. 1950;95(34):141–6.

    PubMed  CAS  Google Scholar 

  44. Wjst M, Dold S. Genes, factor X, and allergens: what causes allergic diseases? Allergy. 1999;54(7):757–9.

    PubMed  CAS  Google Scholar 

  45. Rajakumar K. Vitamin D, cod-liver oil, sunlight, and rickets: a historical perspective. Pediatrics. 2003;112(2):e132–5.

    PubMed  Google Scholar 

  46. USDA National Nutrient Database for Standard Reference, Release 24 [database on the Internet], 2012. http://ndb.nal.usda.gov/ndb/foods/show/674. Accessed March 26, 2012.

  47. Althouse AD, Turnquist CH, Bracciano AF. Modern refrigeration and air conditioning. 18th ed. Tinley Park: Goodheart-Willcox Co; 2003.

    Google Scholar 

  48. Magoun AB. Television: the life story of a technology. Westport: Greenwood Press; 2007.

    Google Scholar 

  49. Litonjua AA, Weiss ST. Is vitamin D deficiency to blame for the asthma epidemic? J Allergy Clin Immunol. 2007;120(5):1031–5.

    PubMed  CAS  Google Scholar 

  50. Raby BA, Lazarus R, Silverman EK, et al. Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am J Respir Crit Care Med. 2004;170(10):1057–65.

    PubMed  Google Scholar 

  51. Poon AH, Laprise C, Lemire M, et al. Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am J Respir Crit Care Med. 2004;170(9):967–73.

    PubMed  Google Scholar 

  52. Saadi A, Gao G, Li H, Wei C, Gong Y, Liu Q. Association study between vitamin D receptor gene polymorphisms and asthma in the Chinese Han population: a case-control study. BMC Med Genet. 2009;10:71.

    PubMed  Google Scholar 

  53. Vollmert C, Illig T, Altmuller J, et al. Single nucleotide polymorphism screening and association analysis—exclusion of integrin beta 7 and vitamin D receptor (chromosome 12q) as candidate genes for asthma. Clin Exp Allergy. 2004;34(12):1841–50.

    PubMed  CAS  Google Scholar 

  54. Wjst M. Variants in the vitamin D receptor gene and asthma. BMC Genet. 2005;6(1):2.

    PubMed  Google Scholar 

  55. Wjst M, Altmuller J, Faus-Kessler T, Braig C, Bahnweg M, Andre E. Asthma families show transmission disequilibrium of gene variants in the vitamin D metabolism and signalling pathway. Respir Res. 2006;7:60.

    PubMed  Google Scholar 

  56. Wittke A, Weaver V, Mahon BD, August A, Cantorna MT. Vitamin D receptor-deficient mice fail to develop experimental allergic asthma. J Immunol. 2004;173(5):3432–6.

    PubMed  CAS  Google Scholar 

  57. Wittke A, Chang A, Froicu M, et al. Vitamin D receptor expression by the lung micro-­environment is required for maximal induction of lung inflammation. Arch Biochem Biophys. 2007;460(2):306–13.

    PubMed  CAS  Google Scholar 

  58. Bosse Y, Maghni K, Hudson TJ. 1alpha,25-Dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes. Physiol Genomics. 2007;29(2):161–8.

    PubMed  CAS  Google Scholar 

  59. Haussler MR, Haussler CA, Bartik L, et al. Vitamin D receptor: molecular signaling and actions of nutritional ligands in disease prevention. Nutr Rev. 2008;66(10 Suppl 2):S98–112.

    PubMed  Google Scholar 

  60. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol. 2005;289(1):F8–28.

    PubMed  CAS  Google Scholar 

  61. Strachan DP. Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax. 2000;55:S2–10.

    PubMed  Google Scholar 

  62. Ramsey CD, Celedon JC. The hygiene hypothesis and asthma. Curr Opin Pulm Med. 2005;11(1): 14–20.

    PubMed  Google Scholar 

  63. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children. Am J Respir Crit Care Med. 2008;178(7):667–72.

    PubMed  Google Scholar 

  64. Corne JM, Marshall C, Smith S, et al. Frequency, severity, and duration of rhinovirus infections in asthmatic and non-asthmatic individuals: a longitudinal cohort study. Lancet. 2002;359(9309):831–4.

    PubMed  Google Scholar 

  65. Liu PT, Stenger S, Tang DH, Modlin RL. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. J Immunol. 2007;179(4):2060–3.

    PubMed  CAS  Google Scholar 

  66. Grant WB. Hypothesis—ultraviolet-B irradiance and vitamin D reduce the risk of viral infections and thus their sequelae, including autoimmune diseases and some cancers. Photochem Photobiol. 2008;84(2):356–65.

    PubMed  CAS  Google Scholar 

  67. Herr C, Shaykhiev R, Bals R. The role of cathelicidin and defensins in pulmonary inflammatory diseases. Expert Opin Biol Ther. 2007;7(9):1449–61.

    PubMed  CAS  Google Scholar 

  68. Urashima M, Segawa T, Okazaki M, Kurihara M, Wada Y, Ida H. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr. 2010;91(5):1255–60.

    PubMed  CAS  Google Scholar 

  69. Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol. 2011;127(5):1294–6.

    PubMed  Google Scholar 

  70. Dickson I. New approaches to vitamin D. Nature. 1987;325(6099):18.

    PubMed  CAS  Google Scholar 

  71. Minghetti PP, Norman AW. 1,25(OH)2-vitamin D3 receptors: gene regulation and genetic circuitry. FASEB J. 1988;2(15):3043–53.

    PubMed  CAS  Google Scholar 

  72. Akeno N, Saikatsu S, Kawane T, Horiuchi N. Mouse vitamin D-24-hydroxylase: molecular cloning, tissue distribution, and transcriptional regulation by 1alpha,25-dihydroxyvitamin D3. Endocrinology. 1997;138(6):2233–40.

    PubMed  CAS  Google Scholar 

  73. Mahon BD, Wittke A, Weaver V, Cantorna MT. The targets of vitamin D depend on the differentiation and activation status of CD4 positive T cells. J Cell Biochem. 2003;89(5):922–32.

    PubMed  CAS  Google Scholar 

  74. Heine G, Anton K, Henz BM, Worm M. 1alpha,25-Dihydroxyvitamin D3 inhibits anti-CD40 plus IL-4-mediated IgE production in vitro. Eur J Immunol. 2002;32(12):3395–404.

    PubMed  CAS  Google Scholar 

  75. Adorini L, Penna G, Giarratana N, et al. Dendritic cells as key targets for immunomodulation by Vitamin D receptor ligands. J Steroid Biochem Mol Biol. 2004;89–90(1–5):437–41.

    PubMed  Google Scholar 

  76. Cantorna MT, Zhu Y, Froicu M, Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am J Clin Nutr. 2004;80(6 Suppl):1717S–20.

    PubMed  CAS  Google Scholar 

  77. Matheu V, Back O, Mondoc E, Issazadeh-Navikas S. Dual effects of vitamin D-induced alteration of TH1/TH2 cytokine expression: enhancing IgE production and decreasing airway eosinophilia in murine allergic airway disease. J Allergy Clin Immunol. 2003;112(3):585–92.

    PubMed  CAS  Google Scholar 

  78. Iho S, Kura F, Sugiyama H, Takahashi T, Hoshino T. The role of monocytes in the suppression of PHA-induced proliferation and IL 2 production of human mononuclear cells by 1,25-dihydroxyvitamin D3. Immunol Lett. 1985;11(5–6):331–6.

    PubMed  CAS  Google Scholar 

  79. Reichel H, Koeffler HP, Tobler A, Norman AW. 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc Natl Acad Sci USA. 1987;84(10):3385–9.

    PubMed  CAS  Google Scholar 

  80. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, O’Garra A. 1alpha,25-Dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol. 2001;167(9):4974–80.

    PubMed  CAS  Google Scholar 

  81. Cantorna MT, Woodward WD, Hayes CE, DeLuca HF. 1,25-Dihydroxyvitamin D3 is a positive regulator for the two anti-encephalitogenic cytokines TGF-beta 1 and IL-4. J Immunol. 1998;160(11):5314–9.

    PubMed  CAS  Google Scholar 

  82. Topilski I, Flaishon L, Naveh Y, Harmelin A, Levo Y, Shachar I. The anti-inflammatory effects of 1,25-dihydroxyvitamin D3 on Th2 cells in vivo are due in part to the control of integrin-mediated T lymphocyte homing. Eur J Immunol. 2004;34(4):1068–76.

    PubMed  CAS  Google Scholar 

  83. McGlade JP, Gorman S, Zosky GR, et al. Suppression of the asthmatic phenotype by ultraviolet B-induced, antigen-specific regulatory cells. Clin Exp Allergy. 2007;37(9):1267–76.

    PubMed  CAS  Google Scholar 

  84. Pichler J, Gerstmayr M, Szepfalusi Z, Urbanek R, Peterlik M, Willheim M. 1Alpha,25(OH)2D3 inhibits not only Th1 but also Th2 differentiation in human cord blood T cells. Pediatr Res. 2002;52(1):12–8.

    PubMed  CAS  Google Scholar 

  85. Annesi-Maesano I. Perinatal events, vitamin D, and the development of allergy. Pediatr Res. 2002;52(1):3–5.

    PubMed  Google Scholar 

  86. Gregori S, Casorati M, Amuchastegui S, Smiroldo S, Davalli AM, Adorini L. Regulatory T cells induced by 1 alpha,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol. 2001;167(4):1945–53.

    PubMed  CAS  Google Scholar 

  87. Gregori S, Giarratana N, Smiroldo S, Uskokovic M, Adorini L. A 1alpha,25-dihydroxyvitamin D(3) analog enhances regulatory T-cells and arrests autoimmune diabetes in NOD mice. Diabetes. 2002;51(5):1367–74.

    PubMed  CAS  Google Scholar 

  88. Meehan MA, Kerman RH, Lemire JM. 1,25-Dihydroxyvitamin D3 enhances the generation of nonspecific suppressor cells while inhibiting the induction of cytotoxic cells in a human MLR. Cell Immunol. 1992;140(2):400–9.

    PubMed  CAS  Google Scholar 

  89. Schwartz RH. Natural regulatory T cells and self-tolerance. Nat Immunol. 2005;6(4):327–30.

    PubMed  CAS  Google Scholar 

  90. Chatenoud L, Salomon B, Bluestone JA. Suppressor T cells—they’re back and critical for regulation of autoimmunity! Immunol Rev. 2001;182:149–63.

    PubMed  CAS  Google Scholar 

  91. Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr. 2003;23:117–45.

    PubMed  CAS  Google Scholar 

  92. D’Ambrosio D, Cippitelli M, Cocciolo MG, et al. Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J Clin Invest. 1998;101(1):252–62.

    PubMed  Google Scholar 

  93. Xing N, Maldonado ML, Bachman LA, McKean DJ, Kumar R, Griffin MD. Distinctive dendritic cell modulation by vitamin D(3) and glucocorticoid pathways. Biochem Biophys Res Commun. 2002;297(3):645–52.

    PubMed  CAS  Google Scholar 

  94. Yu XP, Bellido T, Manolagas SC. Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc Natl Acad Sci USA. 1995;92(24):10990–4 [Erratum in: Proc Natl Acad Sci USA 1996 January 9;93(1):524].

    PubMed  CAS  Google Scholar 

  95. Cippitelli M, Santoni A. Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur J Immunol. 1998;28(10):3017–30.

    PubMed  CAS  Google Scholar 

  96. Xystrakis E, Kusumakar S, Boswell S, et al. Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest. 2006;116(1):146–55.

    PubMed  CAS  Google Scholar 

  97. Banerjee A, Damera G, Bhandare R, et al. Vitamin D and glucocorticoids differentially modulate chemokine expression in human airway smooth muscle cells. Br J Pharmacol. 2008;155(1):84–92.

    PubMed  CAS  Google Scholar 

  98. Taher YA, van Esch BC, Hofman GA, Henricks PA, van Oosterhout AJ. 1alpha,25-Dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J Immunol. 2008;180(8):5211–21.

    PubMed  CAS  Google Scholar 

  99. Chi A, Wildfire J, McLoughlin R, et al. Umbilical cord plasma 25-hydroxyvitamin D concentration and immune function at birth: the Urban Environment and Childhood Asthma study. Clin Exp Allergy. 2011;41(6):842–50.

    PubMed  CAS  Google Scholar 

  100. Burri PH. Fetal and postnatal development of the lung. Annu Rev Physiol. 1984;46:617–28.

    PubMed  CAS  Google Scholar 

  101. Marin L, Dufour ME, Nguyen TM, Tordet C, Garabedian M. Maturational changes induced by 1 alpha,25-dihydroxyvitamin D3 in type II cells from fetal rat lung explants. Am J Physiol. 1993;265(1 Pt 1):L45–52.

    PubMed  CAS  Google Scholar 

  102. Marin L, Dufour ME, Tordet C, Nguyen M. 1,25(OH)2D3 stimulates phospholipid biosynthesis and surfactant release in fetal rat lung explants. Biol Neonate. 1990;57(3–4):257–60.

    PubMed  CAS  Google Scholar 

  103. Nguyen M, Trubert CL, Rizk-Rabin M, et al. 1,25-Dihydroxyvitamin D3 and fetal lung maturation: immunogold detection of VDR expression in pneumocytes type II cells and effect on fructose 1,6 bisphosphatase. J Steroid Biochem Mol Biol. 2004;89–90(1–5):93–7.

    PubMed  Google Scholar 

  104. Nguyen TM, Guillozo H, Marin L, Tordet C, Koite S, Garabedian M. Evidence for a vitamin D paracrine system regulating maturation of developing rat lung epithelium. Am J Physiol. 1996;271(3 Pt 1):L392–9.

    PubMed  CAS  Google Scholar 

  105. Nguyen M, Guillozo H, Garabedian M, Balsan S. Lung as a possible additional target organ for vitamin D during fetal life in the rat. Biol Neonate. 1987;52(4):232–40.

    PubMed  CAS  Google Scholar 

  106. Rehan VK, Torday JS, Peleg S, et al. 1alpha,25-Dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxy vitamin D3: production and biological activity studies in pulmonary alveolar type II cells. Mol Genet Metab. 2002;76(1):46–56.

    PubMed  CAS  Google Scholar 

  107. Phokela SS, Peleg S, Moya FR, Alcorn JL. Regulation of human pulmonary surfactant protein gene expression by 1alpha,25-dihydroxyvitamin D3. Am J Physiol Lung Cell Mol Physiol. 2005;289(4):L617–26.

    PubMed  CAS  Google Scholar 

  108. Gaultier C, Harf A, Balmain N, Cuisinier-Gleizes P, Mathieu H. Lung mechanics in rachitic rats. Am Rev Respir Dis. 1984;130(6):1108–10.

    PubMed  CAS  Google Scholar 

  109. Zosky GR, Berry LJ, Elliot JG, James AL, Gorman S, Hart PH. Vitamin D deficiency causes deficits in lung function and alters lung structure. Am J Resp Crit Care Med. 2011;183(10):1336–43.

    PubMed  Google Scholar 

  110. Brun P, Dupret JM, Perret C, Thomasset M, Mathieu H. Vitamin D-dependent calcium-binding proteins (CaBPs) in human fetuses: comparative distribution of 9K CaBP mRNA and 28K CaBP during development. Pediatr Res. 1987;21(4):362–7.

    PubMed  CAS  Google Scholar 

  111. Lunghi B, Meacci E, Stio M, et al. 1,25-Dihydroxyvitamin D3 inhibits proliferation of IMR-90 human fibroblasts and stimulates pyruvate kinase activity in confluent-phase cells. Mol Cell Endocrinol. 1995;115(2):141–8.

    PubMed  CAS  Google Scholar 

  112. Stio M, Celli A, Lunghi B, Raugei G, Modesti A, Treves C. Vitamin D receptor in IMR-90 human fibroblasts and antiproliferative effect of 1,25-dihydroxyvitamin D3. Biochem Mol Biol Int. 1997;43(6):1173–81.

    PubMed  CAS  Google Scholar 

  113. Stio M, Lunghi B, Celli A, Nassi P, Treves C. Effect of 1,25-dihydroxyvitamin D3 on proliferation in senescent IMR-90 human fibroblasts. Mech Ageing Dev. 1996;91(1):23–36.

    PubMed  CAS  Google Scholar 

  114. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128(6):3792–8.

    PubMed  CAS  Google Scholar 

  115. Damera G, Fogle H, Lim P, et al. Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. Br J Pharmacol. 2009;158:1429–41.

    PubMed  CAS  Google Scholar 

  116. Gupta A, Sjoukes A, Richards D, et al. Relationship between serum vitamin D, disease severity and airway remodeling in children with asthma. Am J Respir Crit Care Med. 2011;84(12):1342–9.

    Google Scholar 

  117. Litonjua AA. Vitamin D deficiency as a risk factor for childhood allergic disease and asthma. Curr Opin Allergy Clin Immunol. 2012.

    Google Scholar 

  118. Krstic G. Asthma prevalence associated with geographical latitude and regional insolation in the United States of America and Australia. PLoS One. 2011;6(4):e18492.

    PubMed  CAS  Google Scholar 

  119. Hughes AM, Lucas RM, Ponsonby AL, et al. The role of latitude, ultraviolet radiation exposure and vitamin D in childhood asthma and hayfever: an Australian multicenter study. Pediatr Allergy Immunol. 2011;22(3):327–33.

    PubMed  Google Scholar 

  120. Arnedo-Pena A, Garcia-Marcos L, Fernandez-Espinar JF, et al. Sunny hours and variations in the prevalence of asthma in schoolchildren according to the International Study of Asthma and Allergies (ISAAC) Phase III in Spain. Int J Biometeorol. 2011;55(3):423–34.

    PubMed  Google Scholar 

  121. Devereux G, Litonjua AA, Turner S, et al. Maternal vitamin D intake during pregnancy and early childhood wheezing. Am J Clin Nutr. 2007;85:853–9.

    PubMed  CAS  Google Scholar 

  122. Camargo JCA, Rifas-Shiman SL, Litonjua AA, et al. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at age 3 years. Am J Clin Nutr. 2007;85:788–95.

    PubMed  CAS  Google Scholar 

  123. Erkkola M, Kaila M, Nwaru BI, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009;39(6):875–82.

    PubMed  CAS  Google Scholar 

  124. Miyake Y, Sasaki S, Tanaka K, Hirota Y. Dairy food, calcium and vitamin D intake in pregnancy, and wheeze and eczema in infants. Eur Respir J. 2010;35(6):1228–34.

    PubMed  CAS  Google Scholar 

  125. Gale CR, Robinson SM, Harvey NC, et al. Maternal vitamin D status during pregnancy and child outcomes. Eur J Clin Nutr. 2007;62:68–77.

    PubMed  Google Scholar 

  126. Morales E, Romieu I, Guerra S, et al. Maternal vitamin D Status in pregnancy and risk of lower respiratory tract infections, wheezing, and asthma in offspring. Epidemiology. 2012;23(1):64–71.

    PubMed  Google Scholar 

  127. Camargo Jr CA, Ingham T, Wickens K, et al. Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics. 2011;127(1):e180–7.

    PubMed  Google Scholar 

  128. Rothers J, Wright AL, Stern DA, Halonen M, Camargo Jr CA. Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. J Allergy Clin Immunol. 2011;128(5):1093–9. e5.

    PubMed  CAS  Google Scholar 

  129. Sidbury R, Sullivan AF, Thadhani RI, Camargo Jr CA. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br J Dermatol. 2008;159(1):245–7.

    PubMed  CAS  Google Scholar 

  130. Javanbakht MH, Keshavarz SA, Djalali M, et al. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatol Treat. 2011;22(3):144–50.

    CAS  Google Scholar 

  131. Litonjua AA. Dietary factors and the development of asthma. Immunol Allergy Clin North Am. 2008;28(3):603–29. ix.

    PubMed  Google Scholar 

  132. Devereux G, Wilson A, Avenell A, McNeill G, Fraser WD. A case-control study of vitamin D status and asthma in adults. Allergy. 2010;65(5):666–7.

    PubMed  CAS  Google Scholar 

  133. Freishtat RJ, Iqbal SF, Pillai DK, et al. High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. J Pediatr. 2010;156(6):948–52.

    PubMed  Google Scholar 

  134. Alyasin S, Momen T, Kashef S, Alipour A, Amin R. The relationship between serum 25 hydroxy vitamin D levels and asthma in children. Allergy Asthma Immunol Res. 2011;3(4):251–5.

    PubMed  CAS  Google Scholar 

  135. Bener A, Ehlayel MS, Tulic MK, Hamid Q. Vitamin D deficiency as a strong predictor of asthma in children. Int Arch Allergy Immunol. 2012;157(2):168–75.

    PubMed  CAS  Google Scholar 

  136. Chinellato I, Piazza M, Sandri M, et al. Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma. Eur Respir J. 2011;37(6):1366–70.

    PubMed  CAS  Google Scholar 

  137. Hypponen E, Berry DJ, Wjst M, Power C. Serum 25-hydroxyvitamin D and IgE—a significant but nonlinear relationship. Allergy. 2009;64(4):613–20.

    PubMed  CAS  Google Scholar 

  138. Wjst M, Hypponen E. Vitamin D serum levels and allergic rhinitis. Allergy. 2007;62(9):1085–6.

    PubMed  CAS  Google Scholar 

  139. Keet CA, McCormack MC, Peng RD, Matsui EC. Age- and atopy-dependent effects of vitamin D on wheeze and asthma. J Allergy Clin Immunol. 2011;128(2):414–6. e5.

    PubMed  Google Scholar 

  140. Sharief S, Jariwala S, Kumar J, Muntner P, Melamed ML. Vitamin D levels and food and environmental allergies in the United States: results from the National Health and Nutrition Examination Survey 2005–2006. J Allergy Clin Immunol. 2011;127(5):1195–202.

    PubMed  CAS  Google Scholar 

  141. Tolppanen AM, Williams D, Henderson J, Lawlor DA. Serum 25-hydroxy-vitamin D and ionised calcium in relation to lung function and allergen skin tests. Eur J Clin Nutr. 2011;65(4):493–500.

    PubMed  CAS  Google Scholar 

  142. Hypponen E, Sovio U, Wjst M, et al. Infant vitamin D supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann N Y Acad Sci. 2004;1037:84–95.

    PubMed  CAS  Google Scholar 

  143. van Oeffelen AA, Bekkers MB, Smit HA, et al. Serum micronutrient concentrations and childhood asthma: the PIAMA birth cohort study. Pediatr Allergy Immunol. 2011;22:784–93.

    PubMed  Google Scholar 

  144. Hollams EM, Hart PH, Holt BJ, et al. Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur Respir J. 2011;38:1320–7.

    PubMed  CAS  Google Scholar 

  145. Back O, Blomquist HK, Hernell O, Stenberg B. Does vitamin D intake during infancy promote the development of atopic allergy? Acta Derm Venereol. 2009;89(1):28–32.

    PubMed  Google Scholar 

  146. Brehm JM, Celedon JC, Soto-Quiros ME, et al. Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am J Respir Crit Care Med. 2009;179(9):765–71.

    PubMed  CAS  Google Scholar 

  147. Brehm JM, Schuemann B, Fuhlbrigge AL, et al. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J Allergy Clin Immunol. 2010;126(1):52–8. e5.

    PubMed  CAS  Google Scholar 

  148. Searing DA, Zhang Y, Murphy JR, Hauk PJ, Goleva E, Leung DY. Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J Allergy Clin Immunol. 2010;125(5):995–1000.

    PubMed  CAS  Google Scholar 

  149. Sutherland ER, Goleva E, Jackson LP, Stevens AD, Leung DY. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir Crit Care Med. 2010;181:699–704.

    PubMed  CAS  Google Scholar 

  150. Peroni DG, Piacentini GL, Cametti E, Chinellato I, Boner AL. Correlation between serum 25-hydroxyvitamin D levels and severity of atopic dermatitis in children. Br J Dermatol. 2011;164(5):1078–82.

    PubMed  CAS  Google Scholar 

  151. Chinellato I, Piazza M, Sandri M, Peroni D, Piacentini G, Boner AL. Vitamin D serum levels and markers of asthma control in Italian children. J Pediatr. 2011;158(3):437–41.

    PubMed  CAS  Google Scholar 

  152. Heaney RP, Armas LA, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr. 2008;87(6):1738–42.

    PubMed  CAS  Google Scholar 

  153. Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol. 2000;48(2):271–2.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Funding: Dr. Litonjua is funded by U01HL091528 from the National Heart, Lung, and Blood Institute; AI056230 from the National Institute of Allergy and Infectious Diseases; and AG027014 from the National Institute of Aging.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Augusto A. Litonjua .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Litonjua, A.A. (2012). The Role of Vitamin D in the Development, Exacerbation, and Severity of Asthma and Allergic Diseases. In: Litonjua, A. (eds) Vitamin D and the Lung. Respiratory Medicine, vol 3. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-61779-888-7_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-61779-888-7_10

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61779-887-0

  • Online ISBN: 978-1-61779-888-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics